7 Select Redness Relief

Manufacturer
7-Select, Inc
Effective date
2025-10-31
Label type
HUMAN OTC DRUG LABEL
Version
8
Source
monthly-update
Hydrated at
2026-06-03 17:39:05

Label at a glance#

Product7 Select Redness Relief
Active ingredientNAPHAZOLINE HYDROCHLORIDE, GLYCERIN
Label structure14 sections

Storage and handling

Other information store at room temperature 15-25 C (59-77F)

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredients                                  Purpose

Glycerin 0.25%......................................Lubricant

Naphazoline HCI 0.012%.........................Redness reliever

OTC - PURPOSE SECTION

Uses

  • for the relief of redness of the eye due to minor eye irritations
  • for the temporary relief of burning and irritation due to dryness of the eye
  • for use as a protectant against further irritation or to relieve dryness of the eye

WARNINGS SECTION

Warings

For external use only

OTC - DO NOT USE SECTION

Do not use if solution changes color or becomes cloudy

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have narrow angle glaucoma

OTC - WHEN USING SECTION

When using this product

  • do not touch tip of container to any surface to avoid contamination
  • replace cap after using
  • pupils may become enlarged temporarily
  • overuse may cause more eye redness
  • remove contact lenses before using

OTC - STOP USE SECTION

Stop use and ask a doctor if

  • you feel eye pain
  • changes in vision occur
  • redness or irritation of the eye lasts
  • condition worsens or lasts more than 72 hours

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away (1-800-222-1222).

INDICATIONS & USAGE SECTION

Directions

  • to open bottle, push cap down and twist counter-clockwise
  • instill 1 to 2 drops in the affected eye(s) up to four time daily
  • children under 6 years of age: ask a doctor

STORAGE AND HANDLING SECTION

Other information

  • store at room temperature 15-25 C (59-77F)

INACTIVE INGREDIENT SECTION

Inactive ingredients

benzalkonium chloride, boric acid, edetate disodium, purified water, sodium borate

DOSAGE & ADMINISTRATION SECTION

Distributed by:

7-Elevin, Inc.

Irving TX 75063

www.7-eleven.com

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Redness Relief Eye DropsRedness Relief Eye Drops

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130052548588502GTIN-13: 0052548588502
EAN-13: 0052548588502
GTIN-12: 052548588502
UPC-A: 052548588502
GTIN storage (14 digits): 00052548588502
24-7 Life.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
e18001c8-33ae-5f66-9cdc-a39724bd4573Product name120140508

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
10202-85010202-850-15

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 7 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
72024-12-02full-release2026-06-01 00:40:10

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
52bddd68-ef16-82e9-e063-6294a90a5ce9b850bed8-8d6d-44ed-976e-3a7b6b6963712026-05-26WarningsExact identifier
spl set id: b850bed8-8d6d-44ed-976e-3a7b6b696371

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.